A potential new Alzheimer’s drug represses the harmful inflammatory response of the brain’s immune cells, reducing disease pathology, preserving neurons, and improving cognition in preclinical tests.
MIT system demonstrates greater than 100-fold improvement in energy efficiency and a 25-fold improvement in compute density compared with current systems.